Spyre Therapeutics CEO Sells $739K in Shares Spyre Therapeutics CEO Turtle Cameron sold $739,000 in stock, disclosed Apr 4, 2026; verify the Form 4 and context before drawing conclusions.

Spyre Therapeutics CEO Sells $739K in Shares: Spyre Therapeutics CEO Turtle Cameron sold $739,000 in stock, disclosed Apr 4, 2026; verify the Form 4 and context before drawing conclusions. 👈 Read full analysis #SpyreTherapeutics #TurtleCameron #StockMarket #CEO #InvestmentNews

Spyre Therapeutics CFO Sells $370k Stake Spyre Therapeutics CFO sold $370,000 of stock (Form 4 filed Apr 3, 2026), a modest-sized exit vs Fazen’s $1.2m median CFO sale in 2025 that warrants context-specific scrutiny.

Spyre Therapeutics CFO Sells $370k Stake: Spyre Therapeutics CFO sold $370,000 of stock (Form 4 filed Apr 3, 2026), a modest-sized exit vs Fazen’s $1.2m median CFO sale in 2025 that warrants context-specific scrutiny. 👈 Read full analysis #SpyreTherapeutics #CFO #StockMarket #Investment #FinanceNews